Determinants of incident chronic kidney disease and progression in a cohort of HIV-infected persons with unrestricted access to health care

HIV Medicine

Volumn 14, Issue 2, 2013, Pages 65-76

  Ganesan, A ^a   Krantz, E M ^b   Huppler Hullsiek, K ^b   Riddle, M S ^a   Weintrob, A C ^c   Lalani, T ^b   Okulicz, J F ^d   Landrum, M ^d   Agan, B ^a   Whitman, T J ^a   Ross, Mj ^e   Crum Cianflone, N F ^f,g   Banks, Susan ^h   Bavaro, Mary ^h   Chun, Helen ^h   Decker, Cathy ^h   Eberly, Lynn ^h   Eggleston, Connor ^h   Fraser, Susan ^h   Hairston, Heather ^h   Hartzell, Josh ^h   Johnson, Arthur ^h   Landrum, Michael ^h   Lifson, Alan ^h   Linfesty, Michelle ^h   Macalino, Grace ^h   Maguire, Jason ^h   Merritt, Scott ^h   O'Connell, Robert ^h   Peel, Sheila ^h   Polis, Michael ^h   Powers, John ^h   Wortmann, Glenn ^h   Zapor, Michael ^h   more..

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d NAVAL MEDICAL CENTER PORTSMOUTH   (United States)

^e SAN ANTONIO MILITARY MEDICAL CENTER   (United States)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^g NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^h Naval Medical Center San Diego ^*

Author keywords

Baseline CD4 count; Ethnicity; Highly active antiretroviral therapy; HIV infection; Kidney disease; Socioeconomic status

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; DIABETES MELLITUS; DISEASE COURSE; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH CARE ACCESS; HEPATITIS B; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK FACTOR;

ADULT; AIDS-ASSOCIATED NEPHROPATHY; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HEALTH SERVICES ACCESSIBILITY; HIV SEROPOSITIVITY; HIV-1; HUMANS; INCIDENCE; INCIDENTAL FINDINGS; MALE; MILITARY PERSONNEL; PROPORTIONAL HAZARDS MODELS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; UNITED STATES; VIRAL LOAD;

EID: 84871931873     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2012.01036.x     Document Type: Article

References (42)

1. Winston JA. Estimating glomerular filtration rate in patients with HIV infection. Semin Nephrol 2008; 28: 576-580.
2. Mocroft A, Kirk O, Gatell J etal. Chronic renal failure among HIV-1-infected patients. AIDS 2007; 21: 1119-1127.
3. Crum-Cianflone N, Ganesan A, Teneza-Mora N etal. Prevalence and factors associated with renal dysfunction among HIV-infected patients. AIDS Patient Care STDS 2010; 24: 353-360.
4. Overton ET, Nurutdinova D, Freeman J, Seyfried W, Mondy KE. Factors associated with renal dysfunction within an urban HIV-infected cohort in the era of highly active antiretroviral therapy. HIV Med 2009; 10: 343-350.
5. Wyatt CM, Winston JA, Malvestutto CD etal. Chronic kidney disease in HIV infection: an urban epidemic. AIDS 2007; 21: 2101-2103.
6. Campbell LJ, Ibrahim F, Fisher M, Holt SG, Hendry BM, Post FA. Spectrum of chronic kidney disease in HIV-infected patients. HIV Med 2009; 10: 329-336.
7. Choi AI, Rodriguez RA, Bacchetti P, Bertenthal D, Volberding PA, O'Hare AM. Racial differences in end-stage renal disease rates in HIV infection versus diabetes. J Am Soc Nephrol 2007; 18: 2968-2974.
8. Lucas GM, Lau B, Atta MG, Fine DM, Keruly J, Moore RD. Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races. J Infect Dis 2008; 197: 1548-1557.
9. Crews DC, Charles RF, Evans MK, Zonderman AB, Powe NR. Poverty, race, and CKD in a racially and socioeconomically diverse urban population. Am J Kidney Dis 2010; 55: 992-1000.
10. Bruce MA, Beech BM, Crook ED etal. Association of socioeconomic status and CKD among African Americans: the Jackson Heart Study. Am J Kidney Dis 2010; 55: 1001-1008.
11. Shoham DA, Vupputuri S, Diez Roux AV etal. Kidney disease in life-course socioeconomic context: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis 2007; 49: 217-226.
12. Ward MM. Socioeconomic status and the incidence of ESRD. Am J Kidney Dis 2008; 51: 563-572.
13. Evans K, Coresh J, Bash LD etal. Race differences in access to health care and disparities in incident chronic kidney disease in the US. Nephrol Dial Transplant 2011; 26: 899-908.
14. Krop JS, Coresh J, Chambless LE etal. A community-based study of explanatory factors for the excess risk for early renal function decline in blacks vs whites with diabetes: the Atherosclerosis Risk in Communities study. Arch Intern Med 1999; 159: 1777-1783.
15. Lucas GM, Mehta SH, Atta MG etal. End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004. AIDS 2007; 21: 2435-2443.
16. Kalayjian RC, Franceschini N, Gupta SK etal. Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease. AIDS 2008; 22: 481-487.
17. Szczech LA, Gange SJ, van der Horst C etal. Predictors of proteinuria and renal failure among women with HIV infection. Kidney Int 2002; 61: 195-202.
18. Winston JA, Klotman ME, Klotman PE. HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection. Kidney Int 1999; 55: 1036-1040.
19. Brodine SK, Starkey MJ, Shaffer RA etal. Diverse HIV-1 subtypes and clinical, laboratory and behavioral factors in a recently infected US military cohort. AIDS 2003; 17: 2521-2527.
20. Marconi VC, Grandits GA, Weintrob AC etal. Outcomes of highly active antiretroviral therapy in the context of universal access to healthcare: the U.S. Military HIV Natural History Study. AIDS Res Ther 2010; 7: 14.
21. Levey AS, Coresh J, Balk E etal. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137-147.
22. Levey AS, Stevens LA, Schmid CH etal. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612.
23. Levey AS, Greene T, Kusek JW, Beck GL, MDRD Study Group. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000; 11: 155A.
24. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992; 41: 1-19.
25. Weintrob AC, Grandits GA, Agan BK etal. Virologic response differences between African Americans and European Americans initiating highly active antiretroviral therapy with equal access to care. J Acquir Immune Defic Syndr 2009; 52: 574-580.
26. Mocroft A, Kirk O, Reiss P etal. Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients. AIDS 2010; 24: 1667-1678.
27. Wyatt CM, Malvestutto C, Coca SG, Klotman PE, Parikh CR. The impact of hepatitis C virus coinfection on HIV-related kidney disease: a systematic review and meta-analysis. AIDS 2008; 22: 1799-1807.
28. Bourgoignie JJ, Meneses R, Ortiz C, Jaffe D, Pardo V. The clinical spectrum of renal disease associated with human immunodeficiency virus. Am J Kidney Dis 1988; 12: 131-137.
29. Gupta SK, Eustace JA, Winston JA etal. Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2005; 40: 1559-1585.
30. Alves TP, Hulgan T, Wu P etal. Race, kidney disease progression, and mortality risk in HIV-infected persons. Clin J Am Soc Nephrol 2010; 5: 2269-2275.
31. Kopp JB, Smith MW, Nelson GW etal. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet 2008; 40: 1175-1184.
32. Branson BM, Handsfield HH, Lampe MA etal. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep 2006; 55: 1-17.
33. Choi AI, Rodriguez RA, Bacchetti P, Bertenthal D, Hernandez GT, O'Hare AM. White/black racial differences in risk of end-stage renal disease and death. Am J Med 2009; 122: 672-678.
34. Choi AI, Shlipak MG, Hunt PW, Martin JN, Deeks SG. HIV-infected persons continue to lose kidney function despite successful antiretroviral therapy. AIDS 2009; 23: 2143-2149.
35. Ross MJ, Klotman PE, Winston JA. HIV-associated nephropathy: case study and review of the literature. AIDS Patient Care STDS 2000; 14: 637-645.
36. Szczech LA, Gupta SK, Habash R etal. The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int 2004; 66: 1145-1152.
37. Bigé N, Lanternier F, Viard JP etal. Presentation of HIV-associated nephropathy and outcome in HAART-treated patients. Nephrol Dial Transplant 2012; 27: 1114-1121.
38. Post FA, Campbell LJ, Hamzah L etal. Predictors of renal outcome in HIV-associated nephropathy. Clin Infect Dis 2008; 46: 1282-1289.
39. National Kidney Foundation. KDOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Available at www.kidney.org/professionals/kdoqi/pdf/ckd_evaluation_classification_stratification.pdf (accessed 21 October 2011).
40. Bleyer AJ, Shemanski LR, Burke GL, Hansen KJ, Appel RG. Tobacco, hypertension, and vascular disease: risk factors for renal functional decline in an older population. Kidney Int 2000; 57: 2072-2079.
41. Yacoub R, Habib H, Lahdo A etal. Association between smoking and chronic kidney disease: a case control study. BMC Public Health 2010; 10: 731.
42. Duncan AE, Lessov-Schlaggar CN, Sartor CE, Bucholz KK. Differences in time to onset of smoking and nicotine dependence by race/ethnicity in a Midwestern sample of adolescents and young adults from a high risk family study. Drug Alcohol Depend 2012 [Epub ahead of print].